Immediate Impact

104 standout
Sub-graph 1 of 18

Citing Papers

Coronary In-Stent Restenosis
2022 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
1 intermediate paper

Works of Hans-Peter Stoll being referenced

One‐Year Results of the CRISTAL Trial, a Randomized Comparison of Cypher Sirolimus‐Eluting Coronary Stents versus Balloon Angioplasty for Restenosis of Drug‐Eluting Stents
2012
Impact of Body Mass Index on the One-Year Clinical Outcome of Patients Undergoing Multivessel Revascularization With Sirolimus-Eluting Stents (from the Arterial Revascularization Therapies Study Part II)††Conflicts of interest: Magdaleen Pieters, Kristel Wittebols, and Hans-Peter Stoll are employees of Cordis Corporation. Joost Daemen received a consultancy fee for his scientific contribution.
2008

Author Peers

Author Last Decade Papers Cites
Hans-Peter Stoll 514 300 435 7 622
Bill Bass 503 360 268 5 566
Sharon Gebhardt 590 224 466 9 657
Nancy B. Morris 640 457 297 5 726
Neal Eigler 552 257 490 18 712
Geoffrey O. Hartzler 502 317 480 9 614
George M. Gura 487 265 592 7 644
Richard S. Stack 345 285 348 9 603
David C. Warth 447 288 393 12 599
María-José Pérez-Vizcayno 471 220 320 10 536
Lowell F Satler 566 437 314 8 661

All Works

Loading papers...

Rankless by CCL
2026